Laurel Copeland to Drug Monitoring
This is a "connection" page, showing publications Laurel Copeland has written about Drug Monitoring.
Connection Strength
0.374
-
Scherrer JF, Salas J, Sullivan MD, Ahmedani BK, Copeland LA, Bucholz KK, Burroughs T, Schneider FD, Lustman PJ. Impact of adherence to antidepressants on long-term prescription opioid use cessation. Br J Psychiatry. 2018 02; 212(2):103-111.
Score: 0.122
-
Owen-Smith A, Stewart C, Green C, Ahmedani BK, Waitzfelder BE, Rossom R, Copeland LA, Simon GE. Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness. Gen Hosp Psychiatry. 2016 Jan-Feb; 38:9-14.
Score: 0.103
-
Zeber JE, Miller AL, Copeland LA, McCarthy JF, Zivin K, Valenstein M, Greenwald D, Kilbourne AM. Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers. Adm Policy Ment Health. 2011 Mar; 38(2):86-95.
Score: 0.076
-
Zeber JE, Copeland LA, Pugh MJ. Variation in antiepileptic drug adherence among older patients with new-onset epilepsy. Ann Pharmacother. 2010 Dec; 44(12):1896-904.
Score: 0.074